Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Both XBcl9 and XPygo2 are required to induce supernumerary axis and dorsal gene activation in Xenopus embryos.
ARX positively regulates Wnt (show WNT2 ELISA Kits)/ beta-catenin (show CTNNB1 ELISA Kits) signaling and the C-terminal domain of ARX interacts with the armadillo (show PKP1 ELISA Kits) repeats in beta-catenin (show CTNNB1 ELISA Kits) to promote Wnt (show WNT2 ELISA Kits)/beta-catenin (show CTNNB1 ELISA Kits) signaling. In addition, we found BCL9 and P300 (show NOTCH1 ELISA Kits) also interact with ARX to modulate Wnt (show WNT2 ELISA Kits)/beta-catenin (show CTNNB1 ELISA Kits) signaling.
Study demonstrates that the Golgi resident protein GM130 (show GOLGA2 ELISA Kits) activates the spindle assembly factor TPX2 (show DAZL ELISA Kits) to nucleate microtubules around the Golgi and further captures them to couple mitotic membranes to the spindle.
Pax6 (show PAX6 ELISA Kits), the master regulator of eye development, directly activates Bcl9/9l transcription.
These results suggest a critical role of BCL9/9-2 in the Wnt (show WNT2 ELISA Kits)-mediated regulation of adult, as opposed to embryonic, myogenic progenitors.
MEF2D (show MEF2D ELISA Kits)-BCL9-positive patients had B-cell precursor immunophenotype and were characterized as being older in age, being resistant to chemotherapy, having very early relapse, and having leukemic blasts that mimic morphologically mature B-cell leukemia with markedly high expression of HDAC9 (show HDAC9 ELISA Kits).
it was demonstrated that miR218 modulated a novel molecular target and the present study provided novel insights into potential mechanisms of RCC (show XRCC1 ELISA Kits) oncogenesis.
findings indicate that BCL9 most likely does not harbor a common genetic variant that can increase the risk for schizophrenia in the Japanese population
BCL9/9L-beta-catenin (show CTNNB1 ELISA Kits) Signaling is Associated With Poor Outcome in Colorectal Cancer
BCL9 is a molecular driver of DCIS invasive progression.
PCDH10 (show PCDH10 ELISA Kits) antagonized MM cell proliferation via the downregulation of Wnt (show WNT2 ELISA Kits)/beta-catenin (show CTNNB1 ELISA Kits)/BCL-9 signaling, whereas PCDH10 (show PCDH10 ELISA Kits) repressed the expression of AKT (show AKT1 ELISA Kits) to promote the expression of GSK3beta (show GSK3b ELISA Kits) and then to restrain the activation of beta-catenin (show CTNNB1 ELISA Kits)
By beta-catenin's association with LEF1 (show LEF1 ELISA Kits) and BCL9-2/B9L (show BCL9L ELISA Kits).
MiR (show MLXIP ELISA Kits)-30-5p downregulation occurs as a result of interaction between multiple myeloma cells and bone marrow stromal cells, which in turn enhances expression of BCL9.
we detected five SNPs in the first two genes/loci - BCL9 and C9orf5 - strongly associated with negative symptoms of schizophrenia
Inhibition of the BCL9-beta-catenin (show CTNNB1 ELISA Kits) interaction and selectively suppresses oncogenic Wnt (show WNT2 ELISA Kits) transcription.
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.
B-cell CLL/lymphoma 9
, B-cell lymphoma 9
, B-cell CLL/lymphoma 9 protein-like
, b-cell CLL/lymphoma 9 protein-like
, B-cell CLL/lymphoma 9 protein
, B-cell lymphoma 9 protein
, nuclear co-factor of beta-catenin signalling
, protein legless homolog